Common terminology criteria for adverse events v6.0 release: what’s new, what’s changed, what’s gone, and what’s still challenging for adverse events reporting in gynecological cancer clinical trials

Sofia Spampinato; Amelia Barcellini; Gemma Eminowicz; Magdalena Anna Stankiewicz; Ewa Burchardt; Barbara Šegedin; Margit Valgma; Remi R.A. Nout; Kari Tanderup; Kathrin Kirchheiner

doi:10.1016/j.ijgc.2025.103665

Common terminology criteria for adverse events v6.0 release: what’s new, what’s changed, what’s gone, and what’s still challenging for adverse events reporting in gynecological cancer clinical trials

International Journal of Gynecological Cancer 2026

View at publisher

Authors: Sofia Spampinato, Amelia Barcellini, Gemma Eminowicz, Magdalena Anna Stankiewicz, Ewa Burchardt, Barbara Šegedin, Margit Valgma, Remi R.A. Nout, Kari Tanderup, Kathrin Kirchheiner

DOI: 10.1016/j.ijgc.2025.103665

Cited by: 0

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions Statistical Methods in Clinical Trials Cancer survivorship and care

Publication details

Journal / source: International Journal of Gynecological Cancer
Volume: 36
Issue: 2
Pages: 103665–103665
Publication date: 1 February 2026
Language: EN